Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Related topics links for Ovarian cancer and MedlinePlus Genetics were removed from the page's related topics section, reducing external resource navigation.
    Difference
    0.2%
    Check dated 2026-08-22T22:35:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added 'Ovarian cancer' as a keyword/related topic and linked MedlinePlus Genetics, and updated the site release version from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-08T20:26:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ovarian cancer keyword and related topics/MedlinePlus Genetics were removed from the study page, reducing disease-context and access to related resources.
    Difference
    0.2%
    Check dated 2026-08-01T18:35:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3, reflecting a new deployment/version of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-25T13:21:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update rather than a change to study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-04T03:50:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, representing a minor metadata update rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-26T23:54:23.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.